Immunocontraceptive vaccines for human use.
The development of safe, effective, reversible contraceptive vaccines for the regulation of human fertility would be a significant addition to our contraceptive armamentarium. However, because we are such an out-bred species, immunological responsiveness to any given vaccine is certain to exhibit a high level of inter-individual variation that will impact upon the efficacy, reversibility and feasibility of the approach. Nevertheless a role for vaccines undoubtedly exists as an aid to birth spacing, particularly in developing countries, and as a non-surgical means of inducing sterility in men. Currently vaccines are being researched that target one of two strategic points in the reproductive process, fertilization and the maternal recognition of pregnancy. Our ability to engineer vaccines that target fertilization is hampered by deficiencies in our knowledge of the molecular mechanisms that regulate this process. However, anti-hCG vaccines have advanced to the stage of clinical trials and appear promising.
Aitken
R John
RJ
Discipline of Biological Sciences, Center for Life Sciences, School of Biological and Chemical Sciences, University of Newcastle, Callaghan, NSW, Australia. jaitken@mail.newcastle.edu.au
D000818:Animals; D000954:Antigens, Surface; D006063:Chorionic Gonadotropin / Q000276:immunology; D003269:Contraception, Immunologic / Q000379:methods* / Q000639:trends; D010064:Embryo Implantation / Q000276:immunology; D005260:Female; D005306:Fertilization / Q000276:immunology; D006801:Humans; D008297:Male; D011247:Pregnancy; D013094:Spermatozoa / Q000276:immunology; D014612:Vaccines / Q000302:isolation & purification / Q000494:pharmacology; D015044:Zona Pellucida / Q000276:immunology
D000954:Antigens, Surface; D006063:Chorionic Gonadotropin; D014612:Vaccines